Position in EXEL
as of Mar 31, 2026
· filed Apr 20, 2026
Position Value
$3,343,790
-$260,657 QoQ
Shares Held
77,962
-5.2% QoQ
Ownership
0.031%
of shares outstanding
% of Portfolio
0.12%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2025
5 quarters on record
Voting authority
Sole 0.6580128780688027.ToString("F0")%
Shared 0.ToString("F0")%
None 99.3419871219312.ToString("F0")%
Common Shares in EXEL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026RITHOLTZ WEALTH MANAGEMENT holds $29,107,183 across 20 Biotechnology names. EXEL ranks #4 (11.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | PBYI |
Puma Biotechnology, Inc.
|
774,308 | $4,947,828 | |
| 2 | AUPH |
Aurinia Pharmaceuticals Inc.
|
314,426 | $4,659,793 | |
| 3 | JAZZ |
Jazz Pharmaceuticals plc
|
19,728 | $3,729,578 | |
| 4 | EXEL |
Exelixis, Inc.
This page
|
77,962 | $3,343,790 | |
| 5 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
4,850 | $2,165,719 | |
| 6 | RIGL |
Rigel Pharmaceuticals Inc
|
78,386 | $2,119,557 | |
| 7 | PTCT |
Ptc Therapeutics, Inc.
|
24,178 | $1,647,247 | |
| 8 | INVA |
Innoviva, Inc.
|
53,180 | $1,239,094 |
All Filings in EXEL
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $3,343,790 | 77,962 | Shares | Sole | 2026-04-20 | |
| 2025-12-31 | $3,604,447 | 82,237 | Shares | Sole | 2026-01-23 | |
| 2025-09-30 | $3,603,135 | 87,243 | Shares | Sole | 2025-10-28 | |
| 2025-06-30 | $2,978,970 | 67,581 | Shares | Sole | 2025-07-28 | |
| 2025-03-31 | $740,024 | 20,044 | Shares | Sole | 2025-04-17 | |
| No filing history on record for this holder in this stock. | ||||||